Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01637 |
| Species: | Homo sapiens |
| Position : | chr12:121799763-121803094 |
| Year: | 2023 |
| Title: | Super Enhancer-Regulated LncRNA LINC01089 Induces Alternative Splicing of DIAPH3 to Drive Hepatocellular Carcinoma Metastasis. |
| Genome Build: | hg38 |
| Enhancer Type: | Super-enhancer |
| Condition: | Disease |
| Disease Name: | hepatocellular carcinoma |
| PMID: | 37756562 |
| MONDO: | MONDO:0007256 |
| Tissue: | liver |
| Tissue Ontology ID: | UBERON:0002107 |
| Cell Source: | Huh-7 |
| CVCL ID: | CVCL_0336 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | SE activity / TF-binding validation; In vivo functional validation |
| High Throughput Method: | H3K27ac ChIP-seq; RNA-seq |
| Low Throughput Method: | Dual-luciferase reporter assay; CRISPRi; ChIP-qPCR; RT-qPCR; E2F1 knockdown/overexpression; In vivo phenotyping |
| Target gene : | LINC01089 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01616 | chr12:121799763-121803094 | liver | hepatocyte | hepatocellular carcinoma |
| E_01617 | chr12:121799763-121803094 | liver | malignant cell | hepatocellular carcinoma |
| E_01638 | chr12:121799763-121803094 | liver | malignant cell | hepatocellular carcinoma |
| E_01666 | chr12:121799763-121803094 | liver | hepatocyte | hepatocellular carcinoma |
| E_01669 | chr12:121799763-121803094 | liver | malignant cell | hepatocellular carcinoma |
| E_01670 | chr12:121799763-121803094 | liver | malignant cell | hepatocellular carcinoma |